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Abstract
Background: Lichtenstein’s technique is considered the reference technique for inguinal hernia repair. Recent trials suggest
that the totally extraperitoneal (TEP) technique may lead to reduced proportions of chronic pain. A systematic review
evaluating the benefits and harms of the TEP compared with Lichtenstein’s technique is needed.
Methodology/Principal Findings: The review was performed according to the ‘Cochrane Handbook for Systematic
Reviews’. Searches were conducted until January 2012. Patients with primary uni- or bilateral inguinal hernias were included.
Only trials randomising patients to TEP and Lichtenstein were included. Bias evaluation and trial sequential analysis (TSA)
were performed. The error matrix was constructed to minimise the risk of systematic and random errors. Thirteen trials
randomized 5404 patients. There was no significant effect of the TEP compared with the Lichtenstein on the number of
patients with chronic pain in a random-effects model risk ratio (RR 0.80; 95% confidence interval (CI) 0.61 to 1.04; p= 0.09).
There was also no significant effect on number of patients with recurrences in a random-effects model (RR 1.41; 95% CI 0.72
to 2.78; p= 0.32) and the TEP technique may or may not be associated with less severe adverse events (random-effects
model RR 0.91; 95% CI 0.73 to 1.12; p= 0.37). TSA showed that the required information size was far from being reached for
patient important outcomes.
Conclusions/Significance: TEP versus Lichtenstein for inguinal hernia repair has been evaluated by 13 trials with high risk of
bias. The review with meta-analyses, TSA and error matrix approach shows no conclusive evidence of a difference between
TEP and Lichtenstein on the primary outcomes chronic pain, recurrences, and severe adverse events.
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Introduction
Inguinal hernia repair is one of the most frequently performed
procedures in surgery and many different techniques have been
suggested. Techniques vary essentially by: using a mesh or not, the
position of the mesh (onlay, inlay or sublay), the approach of the
hernia (anterior or posterior), and the technique being open or
endoscopic. It has been shown that the use of a mesh is associated
with a reduced number of patients with recurrence [1].
Both a systematic review and a meta-analysis without a
systematic review have been published [1,2]. In these, combina-
tions of different techniques are compared in one intervention
group versus combinations of other techniques as a control group.
However, one specific technique for inguinal hernia repair cannot
be claimed to be superior based on the comparisons of
heterogeneous intervention groups [3].
Guidelines in many West European countries consider the
Lichtenstein technique as the reference standard [4]. Recent
reports suggest that a preperitoneal mesh, by the endoscopic
totally extraperitoneal (TEP) method, results in a reduction of
chronic pain and a quicker recovery [2]. Conceptually, the
TEP rather than the transabdominal preperitoneal (TAPP)
approach seems a logic choice as it avoids entering the
abdominal cavity.
A systematic review of randomized trials comparing only the
TEP technique versus only the Lichtenstein technique is needed.
Available evidence needs to be evaluated in the perspective of the
three dimensions of possible risks of errors: the systematic error
(bias), the random error (‘the play of chance’), and the design error
(the outcome measure chosen).
The objective was to conduct a systematic review of the benefits
and harms of the TEP technique compared with the Lichtenstein
technique for inguinal hernia repair.
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Methods
This review was conducted according to the prior published
protocol following the recommendations of the ‘Cochrane
Handbook for Systematic Reviews’ [3] and reported according
to the PRISMA statement (at: www.prisma-statement.org). The
protocol [5] of this review is available online at http://www.ctu.
dk.
Criteria for considering studies for this review
Studies. Only randomized trials were considered for inclu-
sion irrespective language, blinding, publication status, or sample
size. It was intended not to include quasi-randomized trials
regarding assessment of benefits, but it was intended to include
regarding assessment of harms [3].
Patients. Only adult patients were considered. Patients with
primary uni- or bilateral inguinal hernias were included, but
patients with hernia repair for recurrent hernias were excluded
since proportions of patients with chronic pain may differ.
Interventions. Trials using the TEP technique by endoscopy
and any type of mesh for inguinal hernia repair were included.
Trials using the transabdominal preperitoneal (TAPP) technique
were excluded. Trials using both the TEP and TAPP technique
were included only if the vast majority of more than 80% of
interventions were performed with the TEP technique.
The Lichtenstein technique using any type of mesh was
considered the control intervention; trials using any other open
technique were excluded.
Outcomes. The outcome measures were graded according to
the patients’ perspective (GRADE working group 2004) [6].
Primary outcomes were all-cause mortality, chronic pain
defined as persisting pain for longer than three months,
recurrences, and severe adverse events (SAE).
The composite outcome measure of SAE outlined in the
protocol in advance, was constructed summarizing all severe
complications including chronic pain, deep wound infections,
vascular injuries, visceral injuries, and recurrences [5]. It was
recognized that the number of complications may have been
summarized rather than the number of patients with one or more
SAE. Therefore, double counts may have occurred. Since severe
complications in elective hernia repair are rather rare, it is
expected that double counts will be limited to less than 5%.
Secondary outcomes were conversions, time until return to
usual activity, length of hospital stay, and duration of operation
Figure 1. Flow diagram summarizing the search process and results of each phase of the systematic review.
doi:10.1371/journal.pone.0052599.g001
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[5]. Other secondary outcomes were reported according to
availability of data.
Search strategy. Searches included MeSH descriptors
(‘‘Clinical Trials’’, ‘‘Randomized Controlled Trials’’, ‘‘TEP’’,
‘‘TEPP’’, ‘‘totally, extraperitoneal’’, ‘‘Lichtenstein’’, ‘‘Liechten-
stein’’, ‘‘laparoscopic’’, ‘‘Laparoscopy’’, ‘‘preperitoneal’’, ‘‘endo-
scopic’’, ‘‘inguinal hernia’’, ‘‘Hernia, Inguinal’’) and were
performed in CENTRAL on The Cochrane Library (Issue 1
2012), The National Library of Medicine (MEDLINE/PubMed)
(1966–January 2012), and The Intelligent Gateway to Biomedical
& Pharmacological Information (EMBASE) (1980–January 2012)
for randomized trials (Appendix S1). Additional relevant trials
were looked for by checking the reference lists of identified reviews
and randomized trials.
Data collection and analysis. Two authors independently
identified trials for inclusion and extracted the following data: year
and language of publication, country in which the trial was
conducted, duration of the trial, single- or multicenter design, and
in- and exclusion criteria. Further, baseline imbalance and early
stopping of trials were registered. All trial authors were requested
for additional information lacking in their reports. Any differences
in opinion were resolved through discussion.
Assessment of bias risk. The risk of bias of the trials was
assessed by two authors independently, without masking of trial
names, following the instructions given in the Cochrane Handbook for
Systematic Reviews of Interventions [3]. According to empirical
evidence [7–10], risk of bias components were scored as low,
unclear, or high. The following risk of bias components were
extracted from each trial: generation of the allocation sequence,
allocation concealment, blinding (of participants, personnel, and
outcome assessors), incomplete outcome data, selective outcome
reporting, and other bias risks such as academic bias and source of
funding bias.
Trials were classified as trials with low risk of bias only if all risk
of bias components were scored as low. Otherwise, if one or more
of the bias components were scored unclear or with high risk of
bias, the trial was considered to have a high risk of bias.
Error matrix approach. Data on the outcomes of all trials
were assessed for the risk of bias (measured by the level of
evidence), the risk of random error measured by standard error
(SE), and the design error measured by grading the outcomes [11].
Data were presented in a three-dimensional Manhattan error
matrix which may facilitate the overview of available evidence at a
glance and may identify possible lacunae.
Statistical analysis. Meta-analyses were performed accord-
ing to the Cochrane Handbook for Systematic Reviews of Interventions [3]
using Review Manager version 5.1 [12].
For a dichotomous variable, the risk ratio (RR) with the 95%
confidence interval (CI) was calculated if there were two or more
trials for an outcome. For events occurring less than 5% the odds
ratios (OR) with their 95% CI were calculated. The proportion of
patients with the outcome in each group and the p-value for the
comparison between the groups was reported. For continuous
variables, the mean difference (MD) or the standardized mean
difference (SMD) with 95% CI were calculated. For both
dichotomous and continuous outcomes a p-value of less than
0.05 was considered statistically significant.
A random-effects model [13] and a fixed-effect model [14] were
used for meta-analysis in the presence of two or more trials
included under the outcomes. In case of discrepancy between the
two models, both results were reported. Considering the antici-
pated abundant clinical heterogeneity the random-effects model
was emphasized except if one or two trials dominated the available
evidence. Heterogeneity was explored by Cochran’s test. Signif-
icance was set at p-value 0.10, and the quantity of heterogeneity
was measured by I2 [3,15]. The analyses were performed on an
intention-to-treat basis whenever possible. Otherwise, the ‘avail-
able-case analysis’ was adopted [3]. No data for the post-
randomization drop-outs for any of the continuous outcomes
was imputed [16].
Sensitivity analyses. In sensitivity analyses the standard
deviation was imputed from p-values according to the instructions
given in the Cochrane Handbook for Systematic Reviews of Intervention and
the median was used for the meta-analysis when the mean was not
available [3]. If it was not possible to calculate the standard
deviation from the p-value or the confidence interval, the standard
Figure 2. risk of bias summary of all included trials, the eight
criteria on the X-axis. Name of first author and year of trial on
Y-axis. += adequate. 2= inadequate. Blanc= unclear.
doi:10.1371/journal.pone.0052599.g002
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deviation was imputed as the highest standard deviation noted for
that group under that outcome.
Subgroup analyses. It was intended to perform the following
subgroup analyses:
Trials with low risk of bias (all bias components scored as low
risk) compared to trials with high risk of bias (one or more of the
bias components scored as unclear or high risk). Trials were
divided in two groups based on the time of publication. Results of
an initial first group were compared to the results of the second
(last) group to evaluate whether results have improved over time.
Only subgroup analyses showing statistical significant test of
interaction (p,0.05) provided evidence that the intervention effect
may depend on the subgroup.
Bias exploration. It was planned to use a funnel plot to
explore small trial bias [17,18] and to use asymmetry in funnel plot
of trial size against treatment effect to assess this bias.
Trial sequential analysis. Cumulative meta-analyses may
increase type-I errors due to sparse data and repeated significance
testing when updated with new trials [19,20]. To minimise the risk
of type-I errors, trial sequential analysis (TSA) was used. TSA
combines an estimation of the required information size for a
meta-analysis (meta-analysis sample size) with an adjusted
threshold for statistical significance of the meta-analysis [19–21].
The latter, called trial sequential monitoring boundaries (TSMB),
reduce the risk of type-I errors. In TSA the addition of a new trial
in a cumulative meta-analysis is regarded as an interim meta-
analysis and helps to clarify whether additional trials are needed or
not. The idea in TSA is that when the cumulative z-curve crosses
the TSMB, a sufficient level of evidence has been reached and no
further trials may be needed. If the z-curve doesn’t cross one of the
boundaries for benefit, harm or futility and the required
information size has not been reached, there is insufficient
evidence to reach a conclusion [19,20,22,23]. Information size
was calculated as diversity-adjusted required information size [24]
based on an a priori anticipated [5] relative risk reduction of 20%
and by the relative risk reduction of the intervention effect
suggested in a meta-analysis of the included trials. TSA was
performed on all primary outcomes and on all secondary
outcomes showing statistically significant differences between the
two interventions. The required information size was calculated
according to an overall type-I error of 5% and a power of 80%
[24]. The analyses were performed using the TSA program and
manual, developed by The Copenhagen Trial Unit (CTU, Center
for Clinical Intervention Research, Denmark). The TSA software
and manual are available at: www.ctu.dk/tsa.
Results
Altogether the search resulted in 16.902 hits. In each step of
selection, the publication was included in case of any doubt. A
total of 884 hits remained after manual screening of the titles. All
abstracts were reviewed independently by two authors. Double
publications of trial results were considered as one trial. Based on
titles and abstracts 812 publications could be excluded. A total of
72 publications remained for full text evaluation from which 55
were excluded based on the protocol criteria. Finally, seventeen
Figure 3. Hierarchy of outcomes according to importance to patients undergoing inguinal hernia repair (GRADE 2004). Some
outcome measures may be correlated (e.g. recurrence is included in severe adverse events).
doi:10.1371/journal.pone.0052599.g003
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Figure 4. The Manhattan Overview for benefit and harm. 4a: trials and their outcomes with benefit according to the three dimensions;
standard error (SE), graded from patients perspective (0–9) and level of evidence (1a–5). See legends for references to trial numbers I–XIII. 4b: trials
and their outcomes with harm according to the three dimensions; standard error (SE), graded from patients perspective (0–9) and level of evidence
(1a–5). See legends for references to trial numbers I–XIII. Legend for reading Figure 4 The Roman numbers are corresponding to the clinical trials as
TEP versus Lichtenstein, Is TEP Really Better?
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publications describing 13 randomized trials were included
(Figure 1). Additional data of each trial was requested by
contacting the investigators. None of the included trials used
quasi-randomized design.
Patient characteristics and trial designs
All 13 trials used similar inclusion criteria. The specifications of
the exclusion criteria varied. From one of the trials information
was only available as a poster [25]. Arguments for imbalances in
baseline characteristics regarding age, gender, BMI, or ASA
classification were not found (Table 1). One study [26,27]
consisted of three trials; only the trial comparing TEP versus
Lichtenstein was selected. All other trials used a two-arm parallel-
group design [25,26,28–41].
Surgical interventions
In all trials the TEP hernia repair was performed as published
by Voeller [42]. The Lichtenstein technique was performed as
described by Amid [43,44]. One trial had a mixed group of TEP
and TAPP procedures [37]. However, this trial was included since
90% of the patients were operated with the TEP technique
according to personal communication with the author. Open
procedures in all trials were Lichtenstein repairs.
Risk of bias
The risk of bias of the included trials was assessed (Figure 2)
[3,12]. Many bias risk components were unclear. None of the trials
used any form of blinding, especially no blinding of outcome
assessment. In all trials three or more out of eight bias components
were scored as unclear or high risk of bias. Therefore, all trials
were classified as high risk of bias trials.
Error matrix approach
In clinical research there are 3 dimensions that have widely
been recognized to be important.
The included trials were assessed for risks of errors: the risk of
bias measured by the level of evidence, the risk of random error
measured by standard error, and the design error measured by
grading the outcome measures according to GRADE [6,11].
The outcome measures were graded according to the patients’
perspective (Figure 3). All-cause mortality, chronic pain, recur-
rences, and severe adverse events were considered critical for
decision making. Other secondary outcomes were graded impor-
tant, but not critical for decision making.
All trials were assessed as trials with high risk of bias (level of
evidence 1d [11]). The standard errors of the meta-analytic
estimate were calculated (Table 2). Figure 4a&b shows the three-
dimensional ‘Manhattan’ error matrix consisting of the standard
error (SE), the level of evidence and the outcome measures.
The systematic error distinguishes studies based on their risk of
bias. Trials with low risk of bias and data on mortality are absent.
At a glance it is noticed that chronic pain was assessed with low
risk of random error; in five trials the SE’s were between 0.12 and
0.18.
Recurrences are associated with considerable risk of random
error (only one trial has SE of 0.17 and all other trials have
SE’s.0.50). SAE were also assessed with low risk of random error
as five trials had SE’s between 0.09 and 0.18.
Effect of interventions
Thirteen trials randomized 5404 patients for inguinal hernia
repair between the TEP technique (2684 patients) and Lichten-
stein’s technique (2720 patients).
stated below. I = Wright 1996 [41]. II = Merello 1997 [25]. III = Heikkinen 1998 [26]. IV = Moreno 1999 [36]. V = Andersson 2003 [28]. VI = Colak
2003 [29]. VII = Gokalp 2003 [34]. VIII = Hildebrandt 2003 [35]. IX = Lal 2003 [38]. X = Neumayer 2004 [37]. XI = Eklund 2006 [30]. XII = Lau 2006
[40]. XIII = Langeveld 2010 [39].
doi:10.1371/journal.pone.0052599.g004
Table 2. ordering of the available evidence.
Trial
Level of
evidence
All cause
mortality Standard error
Recurrence Chronic pain
Severe adverse
events
I Wright 1996 [41] 1d n/a n/a - 0.18 b 0.18 b
II Merello 1997 [25] 1d n/a z e n/a - z e
III Heikkinen 1998 [26,27] 1d n/a z b z b 0.86 b
IV Moreno 1999 [36] 1d n/a z e n/a - z e
V Andersson 2003 [28] 1d n/a 0.75 b 0.18 h 0.16 h
VI Colak 2003 [29] 1d n/a 0.85 b 0.74 h 0.53 b
VII Gokalp 2003 [34] 1d n/a z e z h z h
VIII Hildebrandt 2003 [35] 1d n/a z h z h z h
IX Lal 2003 [38] 1d n/a z e z h z h
X Neumayer 2004 [37] 1d z 0.17 h 0.12 b 0.09 h
XI Eklund 2006 [30-33] 1d n/a 0.50 h 0.15 b 0.12 b
XII Lau 2006 [40] 1d n/a z e 0.38 b 0.37 b
XIII Langeveld 2010 [39] 1d n/a 0.73 b 0.14 b 0.13 b
Ordering of the available evidence according to levels of evidence (systematic error), standard error (random error) and outcome measures (design error) in TEP versus
Lichtenstein patients. b = benefit, h = harm, e = equal, z = zero events in one or both intervention arms. n/a = no data available.
doi:10.1371/journal.pone.0052599.t002
TEP versus Lichtenstein, Is TEP Really Better?
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Primary outcomes
Mortality. No meta-analysis of all-cause mortality was
performed as only one trial reported mortality with merely two
deaths in the TEP group [37].
Chronic pain. Eleven trials reported on chronic pain defined
as persisting pain for longer than three months, in 334 patients
(12.4%) in 2692 patients in the TEP group versus 454 patients
(16.8%) in 2705 patients in the Lichtenstein group. However,
substantial heterogeneity was present (I2 61%; p= 0.005), and the
random-effects model showed no statistically significant differences
between the TEP and Lichtenstein group (RR 0.80; CI 0.61 to
1.04; p= 0.09). Meta-analysis using the fixed-effect model showed
significant less chronic pain using the TEP technique (RR 0.74; CI
0.65 to 0.84; p,0.00001) (Figure 5a&b).
The TSA, assuming a control event rate of 17%, an anticipated
intervention effect of 20% relative risk reduction (RRR), and a
power of 80%, shows a cumulative z-curve without crossing the
TSMB (Figure 6). Moreover, the z-curve does not even cross the
conventional p = 0.05 boundary, showing lack of evidence to
conclude on the superiority (or futility) in the comparison of the
techniques considering chronic pain.
Recurrences. All 13 trials reported on recurrences with 130
recurrences (5.0%) out of 2583 patients in the TEP group versus
72 recurrences (2.7%) out of 2598 patients in the Lichtenstein
group.
Meta-analysis using the fixed-effect model showed significant
more recurrences in the TEP group (RR 1.89; 95% CI 1.42 to
2.50; p= 0.0001).
Figure 5. Forest plot of Chronic pain. 5a: forest plot on chronic pain. Fixed-effect model. 5b: forest plot on chronic pain. Random-effects model.
doi:10.1371/journal.pone.0052599.g005
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Random-effects meta-analysis showed no statistically significant
difference (RR 1.41; 95% CI 0.72 to 2.78; p= 0.32) I2 = 49%
(Figure 7a,b). Calculations using OR did not show noticeable
difference.
TSA assuming a control event proportion of 3%, an anticipated
intervention effect of 20% RRR, and a power of 80% showed no
crossing of either the TSMB, the conventional boundary, or
futility boundaries (Figure 8). TSA showed that many more
randomized patients are needed before firm evidence can be
reached as the diversity adjusted information size is incalculable.
Severe adverse events. All 13 trials reported on the
composite outcome measure of severe adverse events (SAE)
including all serious complications. There were 509 patients
(18%) with SAE out of 2811 patients in the TEP group versus 559
patients (20%) with SAE out of 2833 patients in the Lichtenstein
group.
Meta-analysis using both the random-effects models (RR 0.91;
CI 0.73 to 1.12; p= 0.37) (I2 = 58%) and the fixed-effect model
(RR 0.92; CI 0.83 to 1.02; p = 0.12) showed no statistical
significant difference between the TEP and the Lichtenstein
technique.
TSA assuming a control event proportion of 20%, an
anticipated intervention effect of 20% RRR and a power of
80% showed that the cumulative z-curve did not cross neither the
TSMB the conventional, nor the futility boundaries (Figure 9).
Secondary outcomes
Conversions. Ten of the 13 trials reported conversion. There
were 168 patients with conversions (7%) in 2425 patients in the
TEP group versus 22 patients with conversions (1%) in 2455
patients in the Lichtenstein group. Meta-analysis using both the
fixed- and random effects models showed significantly more
conversions in the TEP group (fixed-effect model, RR 6.96; 95%
CI 4.58 to 10.58; p = 0.00001). No heterogeneity was present
(I2 = 0%).
TSA assuming a control event proportion of 5%, an anticipated
intervention effect of 20% RRR and a power of 80% showed that
the z-curve did cross the TSMB showing firm evidence that TEP is
associated with substantially more conversions compared to the
Lichtenstein technique (Figure 10).
Time to return to usual activity, hospital stay and
operative time
There was a huge variation in return to usual activity
(I2 = 78%), hospital stay (I2 = 81%), and operative time
(I2 = 96%) in the included trials. Therefore, pooling of data was
not performed.
Figure 6. TSA on chronic pain data. Trial sequential analysis of the effect of TEP vs. Lichtenstein anticipating a realistic relative risk decrease of
chronic pain of 20% with TEP compared to Lichtenstein assuming a control event proportion of 17% and a type 1 error risk of 5% and a type 2 error
risk of 20% (power = 80%). Even in a traditional random-effects meta-analysis the intervention effect is not statistically significant and therefore the
cumulative z-curve does not cross the TSMB for harm, constructed for a diversity-adjusted required information size of 14.666 participants either
suggesting lack of evidence for TEP reducing the proportion of patients with recurrence.
doi:10.1371/journal.pone.0052599.g006
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Other outcomes: persisting numbness. Eight trials re-
ported persisting numbness. There were 70 patients (4.3%) with
persisting numbness out of 1616 patients in the TEP group versus
205 patients (12.5%) out of 1639 patients in the Lichtenstein
group. The random-effects model (I2 = 37%) showed significant
less persisting numbness when using the TEP technique (RR 0.32;
95% CI 0.21 to 0.49).
TSA assuming a control event proportion of 12%, an
anticipated intervention effect of 20% (RRR), and a power of
80% showed that the z-curve did cross the TSMB indicating firm
evidence, notwithstanding the high bias risk, that TEP is
associated with less persisting numbness compared to Lichtenstein.
Subgroup analyses. As none of the trials had low risk of bias
and trial reports did not clearly mention different anaesthesia
techniques, the pre-planned subgroup analyses could not be
conducted. No indications were found that the year of publication
was associated with any of the outcome results. The funnel plots
(Appendix S2) showed no clear arguments for small trial bias
including publication bias [chronic pain: Begg’s test: p = 0.53 (2-
tailed); Egger’s test: p= 0.35 (2-tailed) and SAE: Begg’s test:
p= 0.76 (2-tailed); Egger’s test: p= 0.60 (2-tailed)].
Discussion
This systematic review with meta-analysis included thirteen
trials randomizing 5404 patients comparing the TEP with the
Lichtenstein technique. So far, there is no conclusive evidence of
differences in proportions of patients with chronic pain and
Figure 7. Forest plot on recurrence. 7a: forest plot on recurrence. Fixed-effect model. Figure 7b: forest plot on recurrence. Random-effects
model.
doi:10.1371/journal.pone.0052599.g007
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recurrences between the two techniques. Data have been
evaluated according to the three dimensions of risk of error: bias,
‘play of chance’, and design. Trials fall short on the bias
protection, the included numbers of patients, and the chosen
outcomes. Trial sequential analysis (TSA) and the error matrix
approach were used in addition to conventional meta-analytic
techniques to reach these conclusions, favoring one technique over
the other, based on firm evidence, cannot be drawn yet. There is
neither evidence that one technique favors the other nor for a 20%
non-inferiority comparing the two techniques.
All trials must be classified as having high risk of bias, as they all
scored unclear or high risk of bias in three or more of the eight bias
risk components (Figure 2). Therefore, the meta-analytic effect
estimates in our analyses may eventually appear to overestimate
the effect when trials with low risk of bias emerge [21–23]. In this
review proportions of SAE are high, 18% and 20%, respectively,
in the TEP and Lichtenstein group. These percentages are higher
than the maximally reported in other reviews that include non-
randomized cohorts [1]. However, this is in concordance with
methodological studies showing linkage between unclear/inade-
quate bias control and risk of significant overestimation of
beneficial effects and underestimation of adverse effects [45].
There is substantial risk of random error regarding the primary
outcomes of chronic pain, recurrences, and severe adverse events
(Table 2 and Figure 4a,b). TSA shows that many more
randomized patients may be needed, e.g. 9269 and 6164
respectively, considering chronic pain and SAE before a conclu-
sion on effect or lack of effect can be reached. Recurrence seems to
be so rare that the required number of patients needed to identify
an effect is incalculable.
In this review the outcome measures were graded from the
patients’ point of view according to GRADE, focusing on the
patient important outcomes critical for decision making [6,11].
Chronic pain, recurrence and SAE were considered as such
critical outcomes [5].
Before the use of a mesh became standard (e.g. Bassini’s
technique), recurrence was regarded as the most important
outcome in inguinal surgery. After non-mesh repair using Bassini’s
technique at least 8% of patients may experience recurrence [46].
However, after introduction of the mesh the number of patients
with recurrence is reported as low as 2% with Lichtenstein’s
technique [47]. Reduced numbers of patients with recurrence and
mesh-associated pain have drawn the attention towards another
primary outcome: chronic pain. Up to 40% of patients having
chronic pain has been reported recently after the Lichtenstein’s
technique [48].
It is uncertain whether low-weight or ‘soft’ meshes decrease the
number of patients with chronic pain, however, sufficient data on
the type of mesh was not available from trials included in this
review.
Figure 8. TSA on recurrences TEP versus Lichtenstein. TSA of the effect of TEP vs. Lichtenstein anticipating a realistic relative risk increase of
recurrence of 20% with TEP compared to Lichtenstein assuming a control event proportion of 3%, a type 1 error risk of 5%, and a type 2 error risk of
20% (power = 80%). Even in a traditional random-effects meta-analysis the intervention effect is not statistically significant and therefore the
cumulative z-curve does not cross the TSMB for harm. The required information size is incalculable due to too little information available, suggesting
lack of evidence for TEP reducing the proportion of patients with recurrence.
doi:10.1371/journal.pone.0052599.g008
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This review focuses on primary outcomes, graded as critical for
decision making [6,11]. Secondary outcomes were not considered
to be equally important. Inguinal hernia repair is largely a day-
case procedure [49]. Budget restrictions, logistic arguments,
surgeon’s habits, or organizational procedures may be involved
in different cultural situations making comparison and pooling of
outcomes like hospital stay and operative time unreliable.
Moreover, in the meta-analyses (clinical as well as statistical)
heterogeneity appears to be high. Therefore, from the patients’
perspective, outcomes like hospital stay and duration of operation
should probably be avoided for deciding whether one technique
should be preferred for another as long as critical outcomes have
not been sufficiently evaluated (Figure 3).
Previous reviews suggest lower proportions of chronic pain
associated with TEP [1]. However, these reviews did consider
heterogeneous groups of interventions (TEP and TAPP) and they
conducted a multitude of post hoc subgroup analyses making
conclusions premature and unreliable. Moreover, the superiority
of one technique cannot be claimed based on comparisons of
heterogeneous groups of interventions. There is still a considerable
risk that the advantage of the TEP procedure suggested by the
fixed-effect model, ignoring the large heterogeneity, may turn out
to be the combined result of bias and random-error.
The included trials did not consider any learning curve effect on
both techniques. However, learning curve effects probably do
influence effect estimates. The learning curve of the TEP
technique may be less steep compared to the Lichtenstein
technique, and therefore results of the TEP technique may have
been less favorable than expected. It may be that highly
experienced and dedicated hernia surgeons in large volume
centres produce more favourable results with TEP, regarding the
important outcomes from patients’ perspective. Residents or non
hernia-dedicated surgeons participating in the trials may have
produced the heterogeneous results. Therefore, common clinical
practice and the number of patients with complication ought to be
followed up through clinical databases and compared with
benchmark values [3].
After completing this review, it is concluded that chronic pain
continues to remain an important issue after hernia surgery. Both
techniques (TEP and Lichtenstein) are associated with consider-
able rates of chronic pain. It has to be established whether the
suggested point estimate of the relative risk reduction of
approximately 20% of pain and SAE with TEP is actually ‘‘free’’
of bias and random error.
A priori, a composite outcome measure of SAE including
chronic pain, deep wound infections, vascular injuries, visceral
Figure 9. TSA on severe adverse events TEP vs. Lichtenstein. TSA of the effect of TEP vs. Lichtenstein anticipating a realistic relative risk
reduction of severe adverse event of 20% with TEP compared to Lichtenstein and assuming a control event proportion of 20% and a type 1 error risk
of 5% and a type 2 error risk of 20% (power = 80%). Even in a traditional random-effects meta-analysis the intervention effect is not statistically
significant and therefore the cumulative z-curve does not cross the TSMB constructed for a diversity-adjusted required information size of 11.588
participants suggests lack of firm evidence that TEP reduces the proportion of patients with severe adverse events when the analysis adjusts the
significance level for considering sparse data and repetitive testing on accumulating data.
doi:10.1371/journal.pone.0052599.g009
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injuries and recurrences was constructed [5]. This summary
outcome may have included patients counted twice since
complications are summarized rather than considering the total
number of patients with one or more SAE. Although all trial
authors were contacted repetitively for additional data, their
response rate was low.
However, since the vast majority of patients recover without any
SAE it was hypothesized that this sampling error only occurred
occasionally.
Future trials and studies should be well argued before they are
launched. However, even though databases may provide large
numbers of patients, and, given they inform on consecutive
cohorts of patients and may provide some answers of the actual
status on benefits and harms, they will always be prone to the huge
risk of bias introduced by the choice of intervention by indication.
None of the trials included in this review are large trials in the
sense that they statistically have the power to detect or exclude
even rather large intervention effects on important outcomes.
Therefore, future studies should plan to check their position along
the 3 dimensions of possible errors: bias, ‘the play of chance’ and
the choice of outcomes. It has been proven extensively that trials
with low risk of bias produce more reliable results compared with
trials with high risk of bias [3,10].
Despite how provocative it may seem and based on the above
considerations, it is proposed to conduct a new large trial (or
several trials) with low risk of bias and with outcomes critical for
decision making. These future trials should focus on comparing
techniques each using a preperitoneal mesh position [42,47,49],
Figure 10. TSA shows more conversions for TEP compared to Lichtenstein.
doi:10.1371/journal.pone.0052599.g010
Table 3. Checklist of recommendations for future randomized clinical trials, comparing the TEP with the Lichtenstein technique.
Item Recommendation
To avoid bias The trial report should be able to fulfill the CONSORT statements [50].
To minimize risk of random error The sample size should be exceed e.g. 2000 patients. It may not be just one trial, but at least the total
number of patients accrued in future trials exceed 2000.
To avoid design error One technique, no mixed groups (e.g. just TEP).
Comparator intervention One reference technique (e.g. just Lichtenstein).
Comparison Outcome measures critical for decision making according to the GRADE [6].
To get the evaluation of serious adverse advents (SAE) right Count the patients with one or more SAE, and not just the total number of SAE. This will lead to
less multiple counts and avoid sampling error when the outcome is evaluated.
This outcome may very well be the most important at the end of the day.
Mesh position Preperitoneal (sublay) position.
In an attempt to bridge the information gap a new trial should at least comprise as many patients as the hitherto largest and that preferably several new trials will be needed
with at least as many patients as it takes to produce a boundary break through (boundary for benefit, harm or futility) in the TSA, or in the worst case scenario; to close the
gap between the required and the presently accrued information size.
doi:10.1371/journal.pone.0052599.t003
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and use the present reference technique as comparator (Table 3
[50]).
Supporting Information
Appendix S1 Presents the search strategy that was
followed in the different online libraries, pubmed/
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terms and MeSH terms are described.
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Appendix S2 Presents the Funnel Plots on chronic pain
and severe adverse events. The Begg’s and Egger’s tests are
presented (2-tailed). No arguments for small trial bias were found.
(PDF)
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